MIM
ELGX

MetLife Investment Management’s Endologix Inc ELGX Stock Holding History

MetLife Investment Management’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-4,131
Closed -$234K – 2654
2018
Q2 		$234K Buy
4,131
+2,321
+128% +$118K ﹤0.01% 1854
2018
Q1 		$77K Sell
1,810
-2,596
-59% -$111K ﹤0.01% 2165
2017
Q4 		$236K Buy
+4,406
New +$233K ﹤0.01% 1845

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $8.93B AUM 25.13% 1-Year Est. Return

MetLife Investment Management's ELGX Position: Q3 2018 in Review

MetLife Investment Management sold out of Endologix Inc (ELGX) in Q3 2018, closing a stake of 4,131 shares — an estimated $234K sold.

MetLife Investment Management first reported a position in ELGX in Q4 2017 and held it in 3 quarters. The position peaked at $236K in Q4 2017. 100 funds tracked by Wall St. Rank hold ELGX as of Q3 2018.

  • MetLife Investment Management reported no remaining Endologix Inc position as of Q3 2018 after selling out during the quarter.
  • MetLife Investment Management sold 4,131 Endologix Inc shares in Q3 2018, an estimated $234K.
  • MetLife Investment Management first reported a position in Endologix Inc in Q4 2017 and held it in 3 quarters.
  • MetLife Investment Management's Endologix Inc position peaked at $236K in Q4 2017.
  • 100 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2018.

Based on MetLife Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.